Hidradenitis Suppurativa clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
Sorry, in progress, not accepting new patients
The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in participants with moderate to severe hidradenitis suppurativa (HS).
Sylmar, California and other locations
Last updated: